BrightInsight Appoints David Matthews as Chief Commercial Officer

Matthews brings deep industry expertise to help accelerate commercialization and market expansion efforts

SAN JOSE, Calif, March 3, 2020 – BrightInsight, Inc, the provider of the leading regulated Internet of Things (IoT) platform for biopharma and medtech, today announced the appointment of David Matthews, PhD, as Chief Commercial Officer.

David joins BrightInsight from Boston Consulting Group (BCG) where he was a Partner in the Healthcare, Commercial, and Corporate Finance & Strategy Practices, and helped lead the West Coast Medical Technology business. During his time at BCG, he served healthcare clients in digital strategy, commercial, R&D, and transformation programs. Prior to BCG, David was a computational neuroscientist with more than 20 publications and conference proceedings in machine learning, bioinformatics, brain imaging, and health economics. He holds a PhD in Computational Neurobiology from The University of California, San Diego and the Salk Institute, where he was an NSF Research Fellow, and a BA with honors from Princeton University.

“We are excited to welcome David, who brings deep experience in helping the world’s top biopharma and medtech companies accelerate their digital health journey,” said Kal Patel, MD, CEO and Co-Founder, BrightInsight. “Our team has seen tremendous traction in the marketplace, and David’s strategic leadership will enable us to scale even further as we work to transform patient outcomes globally by bringing the power of digital technology to healthcare.”

“I’m thrilled to join BrightInsight in its mission to accelerate regulated digital health innovation for our customers,” said David Matthews, PhD, Chief Commercial Officer, BrightInsight.“ To make good on the promise of digital health, biopharma and medical device companies need infrastructure that typically sits far outside of their core assets and capabilities today. BrightInsight’s offering delivers on this critical market need. I look forward to building a best-in-class commercial organization that drives further growth and momentum for the world’s leading regulated IoT platform, and thus for the devices, apps and algorithms that will revolutionize patient care.”


BrightInsight provides the leading global regulated Internet of Things (IoT) platform for biopharma and medtech. Every line of code of our BrightInsight Platform is built under a Quality Management System to support and optimize regulated drugs, devices and software through integrated data and actionable insights to enable customers to drive increased patient adherence and engagement. The BrightInsight™ Platform uses software and services to capture, transmit and analyze data from CE-marked and FDA-regulated medical devices, combination products, apps and Software as a Medical Device, in compliance with global security, privacy and regulatory requirements. Deployed as a managed service, the platform accelerates time to market for biopharma and medtech companies, reduces the cost of implementation and maintenance versus a custom solution, and scales across products and global markets. For more information, visit BrightInsight’s website, our blog, Twitter and LinkedIn pages.


Media & Press

Jamie Burgess

Back to News